Latest Regulatory Milestones News

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.

Santana Minerals has been granted a 30-year mining permit for its Bendigo-Ophir Gold Project in Central Otago, surpassing earlier expectations of a 25-year term and providing long-term operational certainty.

Santana Minerals has been granted a crucial 25-year mining permit for its Bendigo-Ophir Gold Project in New Zealand, paving the way for construction and gold production pending environmental approvals.

Imagion Biosystems reports encouraging findings from its Wayne State University collaboration, supporting a lower dose for its MagSense® HER2 imaging agent ahead of a planned FDA IND submission in Q4 2025.

Taiton Resources has secured regulatory approval to launch its first-ever drilling campaign at the Challenger West project in South Australia, targeting promising gold anomalies near a major existing mine.

Far East Gold has secured a pivotal PIPPIB approval for 9,000 hectares of its Idenburg Gold Project in Papua, Indonesia, clearing a major regulatory hurdle and accelerating its path toward mine development.

Bayan Mining has secured US Bureau of Land Management approval for its Desert Star Project in California, paving the way for field activities and a planned drilling program in 2026. The project’s proximity to major rare earth and gold mines underscores its strategic potential.

Mont Royal Resources Limited will have its trading suspension lifted and resume quotation on the ASX from 5 November 2025 following regulatory compliance.

ASF Group's subsidiary ASF Capital has secured AUSTRAC registration as a Digital Currency Exchange provider, marking a regulatory milestone without commencing crypto operations or holding digital assets.

Western Yilgarn NL has significantly expanded its exploration footprint at the Ida Holmes Junction Project to target high-grade gallium mineralisation and secured critical land access for drilling at its West Julimar Bauxite Project in Western Australia.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.

Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.